Intrauterine Contraceptive Market Overview, Growth, and Oppotunities by 2031

MARKET INTRODUCTION

Intrauterine contraceptives are often found in T-shape and are inserted in the uterus to prevent conception. The arms of the device are folded flat, which helps to insert inside the womb, and it is minute in size so that it fits properly inside the womb. Intrauterine contraceptives include either copper or levonorgestrel, which helps in birth control by creating difficulty for the sperm to fertilize the egg. These devices are usually a form of long-acting reversible contraceptives (LARC), which aids in birth control for an extended period. The approximate tenure of these devices lies between 5 to 8 years. These devices have resulted in substantial satisfaction rates among the users of reversible contraceptives due to their cost-effectiveness.

MARKET DYNAMICS

The intrauterine contraceptive market has shown a significant evolution over the forecast period. The growth of the intrauterine contraceptive market is majorly driven by the increasing prevalence of unplanned pregnancy and fewer side-effects of these devices. Moreover, intrauterine contraceptives do not impact the user's mood, libido, and weight and do not even carry the risk for cancer in the future, thereby boosting the market growth. Additionally, focus on women's health and policies by regulatory authorities is fuelling the market growth. In August 2021, the World Health Organisation revised its policies on contraceptive use following new evidence regarding the high risk of HIV in women. The new guidelines state that women should have access to a range of contraception options, HIV prevention, and treatment, such as progestogen-only injectables, implants, and intrauterine devices (IUDs). However, intrauterine contraceptive devices may lead to heavy menstrual bleeding, resulting in painful cramps. Also, the demand for contraceptive pills for shorter period usage is projected to impede the market's growth.

MARKET SCOPE

The "Intrauterine Contraceptive Market Analysis to 2031" is a specialized and in-depth study of the medical device in the healthcare industry, with a specific focus on the global market trend analysis. This report provides an outline of the intrauterine contraceptive market with detailed market segmentation by product, therapeutic application, and end-user. The intrauterine contraceptive market is estimated to witness high growth during the forecast period. It focuses on the vital statistics on the leading players' market status in the intrauterine contraceptive market and offers key opportunities and trends in the market.

MARKET SEGMENTATION

The market is categorized based on the product, therapeutic application, and end user. Based on the product, the market is segmented as hormonal intrauterine devices and copper intrauterine devices. Based on the therapeutic application, the segmentation of the market is into interval insertion (remote pregnancy), post-abortion/post-miscarriage, postpartum, others. Based on end user, segmentation of the market is into hospitals, gynaecology clinics, community healthcare centers, and others.

REGIONAL FRAMEWORK

The report states a detailed outline of the industry, consisting of both qualitative and quantitative information. It gives a sketch and forecast of the intrauterine contraceptive market based on various segments.
The report also consists of market size and forecast estimates from the year 2021 to2031with respect to five primary regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The intrauterine contraceptive market by each region is then subdivided into respective countries and segments. It offers the analysis and forecast of 18 countries worldwide and the recent trend and opportunities prevailing in the region.

The report analyzes factors affecting the intrauterine contraceptive market from both the demand and supply sides. Furthermore, it assesses market dynamics affecting the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also comprises a precise PEST analysis for all five regions, namely, North America, APAC, Europe, MEA, and South & Central America, after evaluating political, social, economic, and technological factors affecting the intrauterine contraceptive market in these regions.

MARKET PLAYERS

The report contains critical developments in the intrauterine contraceptive market as inorganic and organic growth strategies. Various companies are pivoting on organic growth strategies like product approvals, product launches, and others, such as events and patents. Inorganic growth strategies noticed in the market were acquisitions and collaborations &partnerships. Such activities have paved the path for the expansion of the business and customer base of market players. The market players from the intrauterine contraceptive market are anticipated to have profitable growth opportunities in the following years with the increasing demand for intrauterine contraceptive in the global market. Below mentioned is the list of a few companies engaged in the intrauterine contraceptive market.

The report also offers key players' profiles in the intrauterine contraceptive market, along with their SWOT analysis and market strategies. Also, the report focuses on leading market players with information on company profiles, financial information of the last three years, components, and services provided, critical development in the past five years.

•  Bayer AG
  
•  Melbea Innovations
  
•  Novomed Group. (Gyneas)
  
•  Prosan International BV
  
•  Mona Lisa N.V.
  
•  Pregna International Ltd.
  
•  Meril Life Sciences Pvt. Ltd.
  
•  ERENLER MED?KAL
  
•  OCON Medical Ltd.
  
•  AbbVie Inc. (LILETTA)
  

The Insight Partner's dedicated research and analysis team comprises of experienced professionals with advanced statistical expertise and offers various customization options in the current study.

Intrauterine Contraceptive Report Scope